FDC Share Price

Small Cap | Pharmaceuticals and health care | NSE: FDC | BSE: 531599

₹390.15 image-7.35 (-1.85 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 394.10

High (₹) 394.85

Low (₹) 388.05

Prev. Close (₹) 397.50

Volume 5,955

VWAP (₹) 378.76

ROCE (%) 18.55

Industry P/E 43.95

TTM P/E 23.15

P/B Ratio 3.03

Market Cap (₹) Cr.6,364.25

Dividend Yield (%)--

EPS (₹) 18.58

ROE14.42%

Sales Growth (%) 8.92

Profit Growth (%)57.39

Day Range

394.85394.85

L
H

52 Week Range

364.25659.00

L
H

Historical Returns

Returns (6M)

-32.66 %

Returns (1Y)

-8.74 %

Returns (3Y)

49.45 %

Returns (5Y)

86.01 %

Returns (6M)

-32.66 %

Returns (1Y)

-8.74 %

Returns (3Y)

49.45 %

Returns (5Y)

86.01 %

SWOT Analysis

  • Effectively using its capital to generate profits - ROCE improved in the last year
  • Company with (59.35%) TTM EPS Growth
  • Company with no debt
  • Book value per share improving over the last 2 years
  • Efficient in managing Assets to generate Profits - ROA improved since last year
  • Company with 59.35% positive TTM EPS growth
  • Increasing Annual Revenue for Past 2 Years
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 12.28

MFI 18.83

ATR 18.42

Commodity Channel Index -104.80

ROC125 -27.90

ROC21 -19.90

Williams %R -89.51

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current389.50397.15406.55380.10372.45363.05355.40
Week Ago412.19421.97429.34404.82395.04387.67377.89
Month Ago471.90479.90485.95465.85457.85451.80443.80

EMA & SMA
info_icon

390.15

Current Price

EMA & SMApin

Bullish Moving Averages

0

Bearish Moving Averages

20

5 Day 397.95


9 Day 401.36


10 Day 401.67


12 Day 416.75


14 Day 419.33

20 Day 436.68


26 Day 443.55


50 Day 467.82


100 Day 492.59


200 Day 497.07

Deals & Announcements

Bulk and Block Deals

No bulk or block deals available.

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
03 Apr, 2024Nomita Ramdas ChandavarkarAcquisition3,16,56,049BSE
03 Apr, 2024Meera Ramdas ChandavarkarDisposal3,16,56,049BSE
09 Jun, 2022Melarkode Ganesan ParmeswaranAcquisition₹246.593,700BSE
10 Oct, 2020MEERA R. CHANDAVARKARDisposal₹450.003,63,501BSE
10 Oct, 2020ADITI C. BHANOTDisposal₹450.0012,755BSE
10 Oct, 2020NOMITA R. CHANDAVARKARDisposal₹450.0060,407BSE
10 Oct, 2020NANDAN M. CHANDAVARKARDisposal₹450.0057,886BSE
10 Oct, 2020NANDAN M. CHANDAVARKAR in capacity of trustee of Sandhya Mohan Chandavarkar TrustDisposal₹450.002,05,742BSE
10 Oct, 2020AMEYA A. CHANDAVARKAR in capacity of Director of Virgo Advisors Private LimitedDisposal₹450.001,14,332BSE
10 Oct, 2020ASHOK A. CHANDAVARKAR in capacity of Director of Leo Advisors Private LimitedDisposal₹450.001,71,497BSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
07 Nov, 2024Rs.5.0000 per share(500%)First Interim Dividend22 Nov, 202422 Nov, 2024
09 Mar, 2020Rs.0.8000 per share(80%)Interim Dividend19 Mar, 202021 Mar, 2020

Announcements

DateSourceDetail
19 Feb, 2025NSE IndiaFDC Limited has informed the Exchange about order received from Commissioner of Custom
19 Feb, 2025BSE IndiaIntimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015
12 Feb, 2025BSE IndiaIntegrated Filing (Financial) - Unaudited Financial results for the quarter and nine months ended December 31, 2024
12 Feb, 2025NSE IndiaIntegrated Filing (Financial) - Unaudited Financial Results of FDC Limited for the quarter and nine months ended 31st December 2024
12 Feb, 2025BSE IndiaPress release in relation to unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024.
12 Feb, 2025NSE Indiapress release dated February 12, 2025 of FDC Limited for the quarter and nine months ended December 31st 2024
12 Feb, 2025BSE IndiaPFA results for Quarter and Nine months ended December 31, 2024
12 Feb, 2025NSE IndiaFDC Limited has submitted to the Exchange, the financial results for the period ended December 31, 2024.
12 Feb, 2025NSE IndiaFDC Limited has informed the Exchange regarding Board meeting held on February 12, 2025.
12 Feb, 2025BSE IndiaWe hereby inform that the Board at its meeting held on February 12, 2025 has inter alia approved the unaudited (Standalone and Consolidated) Financial results for Quarter and nine months ended 31st December, 2024.

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results & OthersTo consider others business matters.10 Feb, 202512 Feb, 2025
Quarterly Results & OthersTo consider others business matters.10 Feb, 202506 Nov, 2024
Quarterly Results--29 Jul, 202407 Aug, 2024
Audited Results--21 May, 202429 May, 2024
Quarterly Results--30 Jan, 202407 Feb, 2024
Quarterly Results--02 Nov, 202308 Nov, 2023
Quarterly Results & Buy Back of shares--05 Aug, 202309 Aug, 2023
Audited Results--16 May, 202325 May, 2023
Quarterly Results--01 Feb, 202309 Feb, 2023
Quarterly Results--03 Nov, 202214 Nov, 2022

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About FDC

FDC is a Public Limited Listed company incorporated on 23/09/1940 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1940PLC003176 and registration number is 003176. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1916.19 Cr. and Equity Capital is Rs. 16.28 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1940

Managing Director

Mr. Mohan A Chandavarkar

NSE Symbol

FDC

FDC Management

NameDesignation
CA. Uday Kumar GurkarChairman & Ind.Director
Mr. Mohan A ChandavarkarManaging Director
Mr. Nandan M ChandavarkarJoint Managing Director
Mr. Ameya A ChandavarkarExecutive Director & CEO
Mr. Ashok A ChandavarkarExecutive Director
Ms. Nomita R ChandavarkarNon Exe.Non Ind.Director
CA. Swati S MayekarIndependent Director
Dr. Mahesh BijlaniIndependent Director
Mr. Vijay ManiarIndependent Director
Mr. Vijay Nautamlal BhattIndependent Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on FDC

What is the share price of FDC?

The share price of FDC on 13 Mar, 2025 is ₹ 390.15.

What is 52W high and 52W low share price of FDC?

The highest and lowest 52W share prices of FDC are ₹ 659.000 and ₹ 364.250

What is the market cap of FDC?

The market capitalization of FDC as of 13 Mar, 2025 is ₹ 6,364.25 Crores

What is the P/E ratio of FDC?

The current P/E ratio of FDC as of 13 Mar, 2025 is 43.95

What is the PB ratio of FDC?

The PB ratio of FDC as of 13 Mar, 2025 is 3.03

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited